← Back
$TNGX All transactions

Tango Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$304K

Shares

20,251

Price

$15

Filed

Mar 9

Insider

Name

Crystal Adam

Title

President, R&D

CIK

0001825445

Roles

Officer

Transaction Details

Transaction Date

2026-03-05

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

112,622

Footnotes

These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

Filing Info

Accession No.

0001193125-26-098443

Form Type

4

Issuer CIK

0001819133

Crystal Adam's History

Date Ticker Type Value
2026-04-15 TNGX M $200K
2026-04-15 TNGX $962K
2026-04-15 TNGX M $0
2026-04-01 TNGX M $140K
2026-04-01 TNGX $572K
2026-04-01 TNGX M $0
2026-03-25 TNGX M $62K
2026-03-25 TNGX $241K
2026-03-25 TNGX M $0
2026-03-05 TNGX $304K

Other Insiders at TNGX (90d)

Insider Bought Sold Last
Beckman Daniella
Chief Financial Officer
$127K 2026-02-03
Weber Barbara
Director, Executive Chair
$374K 2026-02-03
Crystal Adam
President, R&D
$2.7M 2026-04-15